Health Dictionary Find a Doctor

Vertigo

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

Synonyms and keywords: Dizziness Disequilibrium Lightheadedness Presyncope

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

Overview

Vertigo is identified as ‘room spinning around’. It is a type of dizziness. Presyncope, lightheadedness and disequilibrium are other types of dizziness and should be ruled out. The cause of vertigo can be peripheral or central in origin. In peripheral vertigo, dysfunction is in the vestibular system which includes the vestibule (utricle and saccule), semicircular canals, and the vestibular nerve. Central etiologies of vertigo usually originates from the brainstem or cerebellum. Most common causes of vertigo to appear in primary-care are benign paroxysmal positional vertigo, acute vestibular neuronitis, and Ménière’s disease. Best approach to diagnose vertigo etiology is to obtain a complete history paired with a focal examination including assessment of cranial nerves, nystagmus, sensorineural hearing loss (Rinne or Webers test), otoscopic exam of ear canal and tympanic membrane, HINTS (cover/uncover test), Dix-Hallpike maneuver and/or Hennebert’s sign. Acute/severe attacks of vertigo may subside in a day or two after brainstem compensation. Supportive therapy includes bed rest, antihistamine, antiemetic (prochlorperazine, metoclopramide) to relief the symptom. These drugs should not be used for a long period of time as it may delay the compensatory mechanism in the brainstem and result in the prolongation of vertigo symptom.Treating the underlying cause is the definitive treatment of vertigo.

Historical Perspective

Vertigo is derived from the Latin words vertigin and vertere which means “a whirling or spinning movement,” and “to turn”, respectively.

Classification

Vertigo is typically classified into one of two categories depending on the location of the damaged vestibular pathway. These are peripheral or central vertigo. Each category has a distinct set of characteristics and associated findings. Vertigo can also occur after long flights or boat journeys where the mind gets used to turbulence, resulting in a person feeling as if they are moving up and down. This usually subsides after a few days.

Pathophysiology

Disruption in the vestibular system results in vertigo. The region of disruption could be peripheral (labyrinth, vestibular nerve) or central (brainstem, cerebellum). Vestibulo-ocular reflex is responsible for stabilizing gaze during head movement, it is controlled by six neurotransmitters, which are glutamate, acetylcholine, GABA, dopamine, histamine and norepinephrine.

Causes

Common causes of vertigo are Ménière’s disease, benign paroxysmal positional vertigo, labyrinthitis, vestibular neuritis. Life-threatening causes include brainstem ischemia/hemorrhage, hypertension crisis, drug overdose, cyanide poisoning.

Differentiating Vertigo from other Diseases

Vertigo is one of the four type of dizziness, therefore it must be differentiated from other forms of dizziness, presyncope, lightheadedness and disequilibrium.

Epidemiology and Demographics

Among the patient who presents with dizziness in the primary care setting, fifty-four percent have vertigo upon investigation. Benign paroxysmal positional vertigo, acute vestibular neuronitis, and Ménière’s disease account for ninety-three percent of patients diagnosed with true vertigo in a primary care setting.

Risk Factors

There are no established risk factors for vertigo, as it is a symptom of an underlying disease. However, vertigo can be prevented in some cases by controlling risk factors for the underlying cause.

Screening

There is insufficient evidence to recommend routine screening for vertigo.

Diagnostic Study of Choice

There are no established criteria for the diagnosis of vertigo. The best approach to diagnose vertigo etiology is to obtain a complete history paired with a focal examination.

History and Symptoms

It is important to differentiate between other causes of dizziness before evaluating the cause of vertigo. True vertigo is described as the room spinning around the patient. Once true vertigo is established next step is to identify if the origin of dysfunction is central or peripheral. Detailed investigation of the time course of vertigo and associated signs and symptoms aid in identifying the cause of vertigo.

Physical Examination

Physical examination of patients experiencing vertigo should include assessment of cranial nerves, nystagmus, sensorineural hearing loss (Rinne or Webers test), otoscopic exam of the ear canal and tympanic membrane, HINTS (cover/uncover test), Dix-Hallpike maneuver, and/or Hennebert’s sign.

Laboratory Findings

There are no diagnostic laboratory findings associated with vertigo.

Electrocardiogram

There are no ECG findings associated with vertigo. However, an ECG should be ordered to look for cardiac causes of dizziness including bradycardia, orthostatic hypotension resulting in poor circulation, privided true vertigo is not established as the cause od dizziness in the patient

X-ray

An x-ray of the cervical spine may be helpful in the diagnosis of peripheral vertigo of unknown origin. Findings on an x-ray include, extended cervical spine posture, degenerative changes in the cervical spine can cause peripheral vertigo, and/or uncovertebral arthroses.

Echocardiography or Ultrasound

There are no echocardiography/ultrasound findings associated with vertigo. However, an echocardiography/ultrasound may be helpful in the diagnosis of underlying etiology of vertigo or to rule out cardiac cause of dizziness if true vertigo is not established. Use of echo-color Doppler ultrasound is helpful to look for plaque in extracranial vessels supplying blood to brain in patients with peripheral vertigo but exact cause still unidentified.

CT scan

CT scan is not the first-line imaging method preferred to determine the underlying cause of central vertigo due to its low sensitivity in identifying ischemic stroke and a negative CT scan cannot completely rule out the central cause of vertigo, it still needs to be further investigated with the help of an MRI.

MRI

An MRI is the first-line imaging if the cause of vertigo is suspected to be central in origin. MRI is superior to a CT scan due to its ability to visualize the posterior fossa.

Other Imaging Findings

There are no other imaging findings associated with vertigo. However, some underlying cause may benefit from electronystagmography or electroencephalogram. Further imaging should be conducted according to the diagnostic requirements of the etiology behind the symptom of vertigo.

Other Diagnostic Studies

There are no other diagnostic studies associated with vertigo. However, the causes of vertigo should be evaluated further according to its diagnostic protocol.

Medical Therapy

Acute/severe attacks of vertigo may subside in a day or two after brainstem compensation. Supportive therapy includes bed rest, antihistamine, antiemetic (prochlorperazine, metoclopramide) to relief the symptom. Antihistamine (meclizine,betahistine,dimenhydrinate), antiemetic, anticholinergic (scopolamine) and benzodiazepines (diazepam,lorazepam) are the common medications used to treat vertigo as a symptom. These drugs should not be used for a long period of time as it may delay the compensatory mechanism in the brainstem and result in the prolongation of vertigo symptom. Some patients may be a candidate for vestibular rehabilitation. Treating the underlying cause is the definitive treatment of vertigo.

Surgery

For the majority of underlying causes of vertigo, the mainstay of treatment is medical therapy. Surgery is usually reserved for patients with either tumor-associated vertigo, cholesteatoma, and/or when it does not respond to multiple medical therapies.

Primary Prevention

There are no established measures for the primary prevention of vertigo, as it occurs as a symptom of underlying pathology. In some diseases controlling risk factors or triggering, factors can prevent the disease hence preventing the symptoms.

Secondary Prevention

Effective measures for the secondary prevention of vertigo include optimal treatment of the underlying etiology.

References

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

Overview

Vertigo is derived from the Latin words vertigin and vertere which means “a whirling or spinning movement,” and “to turn”, respectively.

Historical Perspective

  • There is limited information about the historical perspective of vertigo.
  • Vertigo is derived from the Latin words vertigin and vertere which means “a whirling or spinning movement,” and “to turn”, respectively.[1]

References

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

Overview

Vertigo is typically classified into one of two categories depending on the location of the damaged vestibular pathway. These are peripheral or central vertigo. It can also be classified into 3 sub groups based on duration of vertigo. Each category has a distinct set of characteristics and associated findings.

Classification

Vertigo may be classified according to location of dysfunction into 2 subtypes and according to time course/duration into 3 subtypes:

 
 
 
 
 
 
 
Classification of Vertigo[1][2][3]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on Location of Dysfunction
 
 
 
 
 
 
 
Time Course/Duration
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Peripheral
 
Central
 
Lasting a Day or Longer
 
Lasting Minutes to Hours
 
Lasting Seconds
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lesion in inner ear or vestibulocochlear nerve
 
Lesion in brainstem or cerebellum
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ménière’s disease
Benign positional paroxysmal vertigo
Acute labyrinthitis
Acute vestibular neuronitis
Cholesteatoma
Otosclerosis
Perilymphatic fistula
Acoustic Neuroma
 
Brainstem Stroke
Vestibular Migraine
Multiple Sclerosis
Cerebellar ischemia or hemorrhage
Cerebellar tumors
Lateral medullary syndrome
Chiari malformation
 
Vestibular neuronitis
Vertebrobasilar ischemia with labyrinth infarct
Brainstem stroke
Inferior cerebellar infarct/bleed
 
Ménière’s disease
Vertebrobasilar transient ischemic attack (TIA)
Migraine Headache
Perilymph fistula
 
Benign paroxysmal positional vertigo

References

  1. Dieterich, Marianne (2007). “Central vestibular disorders”. Journal of Neurology. 254 (5): 559–568. doi:10.1007/s00415-006-0340-7. ISSN 0340-5354.
  2. Karatas, Mehmet (2008). “Central Vertigo and Dizziness”. The Neurologist. 14 (6): 355–364. doi:10.1097/NRL.0b013e31817533a3. ISSN 1074-7931.
  3. Guerraz, M. (2001). “Visual vertigo: symptom assessment, spatial orientation and postural control”. Brain. 124 (8): 1646–1656. doi:10.1093/brain/124.8.1646. ISSN 1460-2156.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

Overview

It is thought that vertigo is the result of a disruption in the vestibular system. It is identified as peripheral vertigo if the lesion is in the labyrinth or vestibular nerve or central vertigo if the area of disruption originates from the brainstem or cerebellum.

Pathophysiology

Physiology

Pathogenesis

    Pathophysiology of Common Causes of Vertigo[2]
    Ménière’s disease
    Benign paroxysmal positional vertigo
    • Dislodged otoliths stimulate vestibular sense organ.
    Acute labyrinthitis
    Acute vestibular neuritis
    Cholesteatoma
    • Cyst/sac of keratin debris in middle ear.
    Otosclerosis
    • Abnormal bone growth in the middle ear.
    Perilymphatic fistula
    • Abnormal connection between the middle ear and inner ear.

    Genetics

    Vertigo as a symptom has no genetic origin. However, some diseases associated with vertigo can have genetic factors involved:

    Associated Conditions

    Conditions associated with vertigo include:[7]

    Gross Pathology

    There are no gross pathology findings associated with vertigo.

    Microscopic Pathology

    There are no microscopic histopathological characteristic findings associated with vertigo.

    References

    1. “Vertigo”University of Maryland Medical Center. Retrieved 13 November 2015.
    2. Karatas, Mehmet (2008). “Central Vertigo and Dizziness”. The Neurologist. 14 (6): 355–364. doi:10.1097/NRL.0b013e31817533a3. ISSN 1074-7931.
    3. Angelaki, Dora E. (2004). “Eyes on Target: What Neurons Must do for the Vestibuloocular Reflex During Linear Motion”. Journal of Neurophysiology. 92 (1): 20–35. doi:10.1152/jn.00047.2004. ISSN 0022-3077.
    4. Kuo CH, Pang L, Chang R (2008). “Vertigo – part 2 – management in general practice”. Aust Fam Physician. 37 (6): 409–13. PMID 18523693.
    5. Kerber, Kevin A. (2009). “Vertigo and Dizziness in the Emergency Department”. Emergency Medicine Clinics of North America. 27 (1): 39–50. doi:10.1016/j.emc.2008.09.002. ISSN 0733-8627.
    6. Davies R (2004). “Bedside neuro-otological examination and interpretation of commonly used investigations”. J Neurol Neurosurg Psychiatry. 75 Suppl 4: iv32–44. doi:10.1136/jnnp.2004.054478. PMC 1765673. PMID 15564430.
    7. Labuguen RH (2006). “Initial evaluation of vertigo”. Am Fam Physician. 73 (2): 244–51. PMID 16445269.

    Template:WH Template:WS

    Causes

    Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

    Overview

    Common causes of vertigo may include Ménière’s disease, benign paroxysmal positional vertigo, labyrinthitis, vestibular neuritis. Less common causes of vertigo may include mood disorder, anxiety, and migraine. Life-threatening causes include brainstem ischemia/hemorrhage, hypertension crisis, drug overdose, cyanide poisoning.

    Causes

    Common Causes

    • Common causes of vertigo may include:
    Peripheral Vertigo Causes[1]
    Ménière’s disease
    Acoustic neuroma
    Benign paroxysmal positional vertigo
    Acute labyrinthitis
    Acute vestibular neuritis
    Herpes Zoster Oticus
    Cholesteatoma
    • Cyst/sac of keratin debris in middle ear. Fullness/pressure in the ear, vertigo, hearing loss, pain
    Otosclerosis
    • Abnormal bone growth in the middle ear. Vertigo, tinnitus and, sensorineural hearing loss
    Central Vertigo Causes[2]
    Brainstem Stroke
    • Vertigo, imbalance, double vision, slurred speech, and altered consciousness.
    Vestibular Migraine
    • Mostly unilateral severe throbbing headache, vertigo lasting minutes to hours, sensitivity to motion/light/smell/noise, nausea, vomiting, imbalance.
    Multiple Sclerosis
    • Vertigo may accompany other symptoms like vision problem, fatigue, numbness/tingling, limited mobility, bladder/bowel/speech/swallowing impairment.
    Cerebellopontine angle tumors
    Lateral medullary syndrome
    Chiari malformation
    Other Causes
    Medication induced
    Psychogenic


    Less Common Causes


    References

    1. name=”Karatas2008″>Karatas, Mehmet (2008). “Central Vertigo and Dizziness”. The Neurologist. 14 (6): 355–364. doi:10.1097/NRL.0b013e31817533a3. ISSN 1074-7931.
    2. Kerber, Kevin A. (2009). “Vertigo and Dizziness in the Emergency Department”. Emergency Medicine Clinics of North America. 27 (1): 39–50. doi:10.1016/j.emc.2008.09.002. ISSN 0733-8627.
    3. Brantberg, Krister; Trees, Natalie; Baloh, Robert W. (2009). “Migraine-associated vertigo”. Acta Oto-Laryngologica. 125 (3): 276–279. doi:10.1080/00016480510003165. ISSN 0001-6489.
    4. Balaban, Carey D.; Jacob, Rolf G. (2001). “Background and history of the interface between anxiety and vertigo”. Journal of Anxiety Disorders. 15 (1–2): 27–51. doi:10.1016/S0887-6185(00)00041-4. ISSN 0887-6185.

    Template:WH Template:WS

    Differentiating Vertigo from other Diseases

    Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

    Overview

    Many disease cause vertigo as a symptom, following diseases must be investigated as a differential diagnosis for vertigo symptom: Vestibular neuritis, HSV oticus, Meniere disease, labyrinrhine concussion, perilymphatic fistula, semicircular canal dehiscence syndrome, vestibular paroxysmia, Cogan syndrome, vestibular schwannoma, otitis media, aminoglycoside toxicity, recurrent vestibulopathy, vestibular migraine, epileptic vertigo, multiple sclerosis, brain tumors, cerebellar infarction/hemorrhage, brain stem ischemia, chiari malformation, and Parkinson.

    Differentiating Vertigo from Other Diseases

    Differentiating vertigo from other diseases

    Many disease cause vertigo as a symptom, following diseases must be investigated as a differential diagnosis for vertigo symptom: Vestibular neuritis, HSV oticus, Meniere disease, labyrinrhine concussion, perilymphatic fistula, semicircular canal dehiscence syndrome, vestibular paroxysmia, Cogan syndrome, vestibular schwannoma, otitis media, aminoglycoside toxicity, recurrent vestibulopathy, vestibular migraine, epileptic vertigo, multiple sclerosis, brain tumors, cerebellar infarction/hemorrhage, brain stem ischemia, chiari malformation, and Parkinson.[1]

    Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
    Symptoms Physical examination
    Lab Findings Imaging
    Acute onset Recurrency Nystagmus Hearing problems
    Peripheral
    BPPV
    [2][3][4]
    + + +/−
    Vestibular neuritis
    [5]
    + +/− + /−

    (unilateral)

    • + Head thrust test
    HSV oticus
    [6][7][8][9]
    + +/− +/− + VZV antibody titres
    Meniere disease
    [10][11]
    +/− + +/− + (Progressive)
    Labyrinthine concussion
    [12][13]
    + +
    Perilymphatic fistula
    [14][15][16]
    +/− + +
    • CT scan may show fluid around the round window recess
    Semicircular canal

    dehiscence syndrome
    [17][18]

    +/− + +

    (air-bone gaps on audiometry)

    Vestibular paroxysmia
    [19][20][21]
    + + +/−

    (Induced by hyperventilation)

    Cogan syndrome
    [22][23][24]
    + +/− + Increased ESR and cryoglobulins
    • In CT scan we may see calcification or soft tissue attenuation obliterating the intralabyrinthine fluid spaces
    Vestibular schwannoma
    [25][26]
    + +/− +
    Otitis media
    [27][28]
    + +/− Increased acute phase reactants
    Aminoglycoside toxicity
    [29]
    + +
    Recurrent vestibulopathy
    [30][31]
    +
    • It may happen infrequently, every one to two years
    • It may be associated with nausea and vomiting
    • It may overlap with vestibular migraine
    Central
    Vestibular migrain
    [32][33]
    + +/− +/−
    • ICHD-3 criteria
    Epileptic vertigo
    [34]
    + +/−
    • They response well to anti-seizure drugs
    Multiple sclerosis
    [35][36][37]
    + +/− Elevated concentration of CSF oligoclonal bands
    • MS is at least two times more common among women than men
    • The onset of symptoms is mostly between the age of fifteen to forty years, rarely before age fifteen or after age sixty
    Brain tumors
    [38]
    +/− + + + Cerebral spinal fluid (CSF) may show cancerous cells
    • On CT scan most of the brain tumors appears as a hypodense mass lesions
    • On MRI most of the brain tumors appears as a hypointense or isointense on T1-weighted scans, or hyperintense on T2-weighted MRI.
    Cerebellar infarction/hemorrhage + ++/−
    • Based on the time interval between stroke and imaging we may have different presentations
    Brain stem ischemia + +/−
    • Based on the time interval between stroke and imaging we may have different presentations
    • For more information click here
    Chiari malformation
    [39][40]
    + +
    • Patient may experience ringing in the ears
    Parkinson
    [41][42][43]
    +

    ABBREVIATIONS

    VZV= Varicella zoster virus, MRI= Magnetic resonance imaging, ESR= Erythrocyte sedimentation rate, EEG= Electroencephalogram, CSF= Cerebrospinal fluid, GPe= Globus pallidus externa, ICHD= International Classification of Headache Disorders

    References

    1. Labuguen RH (2006). “Initial evaluation of vertigo”. Am Fam Physician. 73 (2): 244–51. PMID 16445269.
    2. Lee SH, Kim JS (June 2010). “Benign paroxysmal positional vertigo”. J Clin Neurol. 6 (2): 51–63. doi:10.3988/jcn.2010.6.2.51. PMC 2895225. PMID 20607044.
    3. Chang MB, Bath AP, Rutka JA (October 2001). “Are all atypical positional nystagmus patterns reflective of central pathology?”. J Otolaryngol. 30 (5): 280–2. PMID 11771020.
    4. Dorresteijn PM, Ipenburg NA, Murphy KJ, Smit M, van Vulpen JK, Wegner I, Stegeman I, Grolman W (June 2014). “Rapid Systematic Review of Normal Audiometry Results as a Predictor for Benign Paroxysmal Positional Vertigo”. Otolaryngol Head Neck Surg. 150 (6): 919–24. doi:10.1177/0194599814527233. PMID 24642523.
    5. Mandalà M, Nuti D, Broman AT, Zee DS (February 2008). “Effectiveness of careful bedside examination in assessment, diagnosis, and prognosis of vestibular neuritis”. Arch. Otolaryngol. Head Neck Surg. 134 (2): 164–9. doi:10.1001/archoto.2007.35. PMID 18283159.
    6. Wackym, Phillip A. (1997). “Molecular Temporal Bone Pathology: II. Ramsay Hunt Syndrome (Herpes Zoster Oticus)”. The Laryngoscope. 107 (9): 1165–1175. doi:10.1097/00005537-199709000-00003. ISSN 0023-852X.
    7. Zhu, S.; Pyatkevich, Y. (2014). “Ramsay Hunt syndrome type II”. Neurology. 82 (18): 1664–1664. doi:10.1212/WNL.0000000000000388. ISSN 0028-3878.
    8. Mishell JH, Applebaum EL (February 1990). “Ramsay-Hunt syndrome in a patient with HIV infection”. Otolaryngol Head Neck Surg. 102 (2): 177–9. doi:10.1177/019459989010200215. PMID 2113244.
    9. Tada, Yuichiro; Aoyagi, Masaru; Tojima, Hitoshi; Inamura, Hiroo; Saito, Osamu; Maeyama, Hiroyuki; Kohsyu, Hidehiro; Koike, Yoshio (2009). “Gd-DTPA Enhanced MRI in Ramsay Hunt Syndrome”. Acta Oto-Laryngologica. 114 (sup511): 170–174. doi:10.3109/00016489409128326. ISSN 0001-6489.
    10. Watanabe, Isamu (1980). “Ménière’s Disease”. ORL. 42 (1–2): 20–45. doi:10.1159/000275477. ISSN 1423-0275.
    11. Saeed SR (January 1998). “Fortnightly review. Diagnosis and treatment of Ménière’s disease”. BMJ. 316 (7128): 368–72. PMC 2665527. PMID 9487176.
    12. Dürrer, J.; Poláčková, J. (1971). “Labyrinthine Concussion”. ORL. 33 (3): 185–190. doi:10.1159/000274994. ISSN 1423-0275.
    13. Choi MS, Shin SO, Yeon JY, Choi YS, Kim J, Park SK (April 2013). “Clinical characteristics of labyrinthine concussion”. Korean J Audiol. 17 (1): 13–7. doi:10.7874/kja.2013.17.1.13. PMC 3936518. PMID 24653897.
    14. Fox, Eileen J.; Balkany, Thomas J.; Arenberg, Kaufman (1988). “The Tullio Phenomenon and Perilymph Fistula”. Otolaryngology–Head and Neck Surgery. 98 (1): 88–89. doi:10.1177/019459988809800115. ISSN 0194-5998.
    15. Casselman JW (February 2002). “Diagnostic imaging in clinical neuro-otology”. Curr. Opin. Neurol. 15 (1): 23–30. PMID 11796947.
    16. Seltzer S, McCabe BF (January 1986). “Perilymph fistula: the Iowa experience”. Laryngoscope. 96 (1): 37–49. PMID 3941579.
    17. Lempert T, von Brevern M (February 2005). “Episodic vertigo”. Curr. Opin. Neurol. 18 (1): 5–9. PMID 15655395.
    18. Watson SR, Halmagyi GM, Colebatch JG (February 2000). “Vestibular hypersensitivity to sound (Tullio phenomenon): structural and functional assessment”. Neurology. 54 (3): 722–8. PMID 10680810.
    19. Hufner, K.; Barresi, D.; Glaser, M.; Linn, J.; Adrion, C.; Mansmann, U.; Brandt, T.; Strupp, M. (2008). “Vestibular paroxysmia: Diagnostic features and medical treatment”. Neurology. 71 (13): 1006–1014. doi:10.1212/01.wnl.0000326594.91291.f8. ISSN 0028-3878.
    20. Strupp M, von Stuckrad-Barre S, Brandt T, Tonn JC (February 2013). “Teaching neuroimages: Compression of the eighth cranial nerve causes vestibular paroxysmia”. Neurology. 80 (7): e77. doi:10.1212/WNL.0b013e318281cc2c. PMID 23400324.
    21. Hüfner K, Barresi D, Glaser M, Linn J, Adrion C, Mansmann U, Brandt T, Strupp M (September 2008). “Vestibular paroxysmia: diagnostic features and medical treatment”. Neurology. 71 (13): 1006–14. doi:10.1212/01.wnl.0000326594.91291.f8. PMID 18809837.
    22. Vollertsen RS (May 1990). “Vasculitis and Cogan’s syndrome”. Rheum. Dis. Clin. North Am. 16 (2): 433–9. PMID 2189159.
    23. Hughes, Gordon B.; Kinney, Sam E.; Barna, Barbara P.; Tomsak, Robert L.; Calabrese, Leonard H. (1983). “Autoimmune reactivity in Cogan’s syndrome: A preliminary report”. Otolaryngology–Head and Neck Surgery. 91 (1): 24–32. doi:10.1177/019459988309100106. ISSN 0194-5998.
    24. Majoor, M. H. J. M.; Albers, F. W. J.; Casselman, J. W. (2009). “Clinical Relevance of Magnetic Resonance Imaging and Computed Tomography in Cogan’s Syndrome”. Acta Oto-Laryngologica. 113 (5): 625–631. doi:10.3109/00016489309135875. ISSN 0001-6489.
    25. Robert W. Foley, Shahram Shirazi, Robert M. Maweni, Kay Walsh, Rory McConn Walsh, Mohsen Javadpour & Daniel Rawluk (2017). “Signs and Symptoms of Acoustic Neuroma at Initial Presentation: An Exploratory Analysis”. Cureus. 9 (11): e1846. doi:10.7759/cureus.1846. PMID 29348989. Unknown parameter |month= ignored (help)
    26. E. P. Lin & B. T. Crane (2017). “The Management and Imaging of Vestibular Schwannomas”. AJNR. American journal of neuroradiology. 38 (11): 2034–2043. doi:10.3174/ajnr.A5213. PMID 28546250. Unknown parameter |month= ignored (help)
    27. “Ear infection – acute: MedlinePlus Medical Encyclopedia”.
    28. Rettig E, Tunkel DE (2014). “Contemporary concepts in management of acute otitis media in children”. Otolaryngol. Clin. North Am. 47 (5): 651–72. doi:10.1016/j.otc.2014.06.006. PMC 4393005. PMID 25213276.
    29. Ernfors P, Duan ML, ElShamy WM, Canlon B (April 1996). “Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3”. Nat. Med. 2 (4): 463–7. PMID 8597959.
    30. Oh AK, Lee H, Jen JC, Corona S, Jacobson KM, Baloh RW (May 2001). “Familial benign recurrent vertigo”. Am. J. Med. Genet. 100 (4): 287–91. PMID 11343320.
    31. Rutka JA, Barber HO (April 1986). “Recurrent vestibulopathy: third review”. J Otolaryngol. 15 (2): 105–7. PMID 3712538.
    32. “The International Classification of Headache Disorders: 2nd edition”. Cephalalgia. 24 Suppl 1: 9–160. 2004. PMID 14979299.
    33. Absinta M, Rocca MA, Colombo B, Copetti M, De Feo D, Falini A, Comi G, Filippi M (December 2012). “Patients with migraine do not have MRI-visible cortical lesions”. J. Neurol. 259 (12): 2695–8. doi:10.1007/s00415-012-6571-x. PMID 22714135.
    34. Tarnutzer AA, Lee SH, Robinson KA, Kaplan PW, Newman-Toker DE (April 2015). “Clinical and electrographic findings in epileptic vertigo and dizziness: a systematic review”. Neurology. 84 (15): 1595–604. doi:10.1212/WNL.0000000000001474. PMC 4408281. PMID 25795644.
    35. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (July 2001). “Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis”. Ann. Neurol. 50 (1): 121–7. PMID 11456302.
    36. Barrett L, Drayer B, Shin C (January 1985). “High-resolution computed tomography in multiple sclerosis”. Ann. Neurol. 17 (1): 33–8. doi:10.1002/ana.410170109. PMID 3985583.
    37. Fazekas F, Barkhof F, Filippi M, Grossman RI, Li DK, McDonald WI, McFarland HF, Paty DW, Simon JH, Wolinsky JS, Miller DH (August 1999). “The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis”. Neurology. 53 (3): 448–56. PMID 10449103.
    38. Dunniway, Heidi M.; Welling, D. Bradley (2016). “Intracranial Tumors Mimicking Benign Paroxysmal Positional Vertigo”. Otolaryngology–Head and Neck Surgery. 118 (4): 429–436. doi:10.1177/019459989811800401. ISSN 0194-5998.
    39. Caldarelli M, Di Rocco C (May 2004). “Diagnosis of Chiari I malformation and related syringomyelia: radiological and neurophysiological studies”. Childs Nerv Syst. 20 (5): 332–5. doi:10.1007/s00381-003-0880-4. PMID 15034729.
    40. Sarnat HB (2008). “Disorders of segmentation of the neural tube: Chiari malformations”. Handb Clin Neurol. 87: 89–103. doi:10.1016/S0072-9752(07)87006-0. PMID 18809020.
    41. van Wensen, E.; van Leeuwen, R.B.; van der Zaag-Loonen, H.J.; Masius-Olthof, S.; Bloem, B.R. (2013). “Benign paroxysmal positional vertigo in Parkinson’s disease”. Parkinsonism & Related Disorders. 19 (12): 1110–1112. doi:10.1016/j.parkreldis.2013.07.024. ISSN 1353-8020.
    42. Steiner I, Gomori JM, Melamed E (1985). “Features of brain atrophy in Parkinson’s disease. A CT scan study”. Neuroradiology. 27 (2): 158–60. PMID 3990948.
    43. Kosta P, Argyropoulou MI, Markoula S, Konitsiotis S (January 2006). “MRI evaluation of the basal ganglia size and iron content in patients with Parkinson’s disease”. J. Neurol. 253 (1): 26–32. doi:10.1007/s00415-005-0914-9. PMID 15981079.

    Template:WH Template:WS

    Epidemiology and Demographics

    Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

    Overview

    Among the patient who presents with dizziness in the primary care setting, fifty-four percent have vertigo upon investigation. Benign paroxysmal positional vertigo, acute vestibular neuronitis, or Ménière’s disease account for ninety-three percent of patients diagnosed with true vertigo in primary care setting. Eighty-percent of patients noticed that vertigo impacted their employment status and increased the need for medical attention. Annual incidence of vertigo is 1.4%. With age prevalence increases. One-year prevalence of vertigo is 5%. Women are two to three times more susceptible than men.

    Epidemiology and Demographics

    Incidence

    Prevalence

    Age

    Gender

    • Women are two to three times more susceptible than men.[4]

    References

    1. 1.0 1.1 Neuhauser HK (2016). “The epidemiology of dizziness and vertigo”. Handb Clin Neurol. 137: 67–82. doi:10.1016/B978-0-444-63437-5.00005-4. PMID 27638063.
    2. Kroenke, Kurt (1992). “Causes of Persistent Dizziness”. Annals of Internal Medicine. 117 (11): 898. doi:10.7326/0003-4819-117-11-898. ISSN 0003-4819.
    3. Hanley K, O’ Dowd T (2002). “Symptoms of vertigo in general practice: a prospective study of diagnosis”. Br J Gen Pract. 52 (483): 809–12. PMC 1316083. PMID 12392120.
    4. Neuhauser, Hannelore; Lempert, Thomas (2009). “Vertigo: Epidemiologic Aspects”. Seminars in Neurology. 29 (05): 473–481. doi:10.1055/s-0029-1241043. ISSN 0271-8235.
    Risk Factors

    Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

    Overview

    Common risk factors in the development of vertigo include: Immunosuppression can provoke Herpes zoster oticus, upper respiratory viral illness can lead to acute vestibular neuritis, drug-induced vertigo: Dose reduction or discontinuation of the medication in patients presenting with vertigo may decrease the future incidence, head injury can trigger epileptic vertigo, changes in head position can provoke vertigo in acute labyrinthitis, benign positional paroxysmal vertigo, cerebellopontine angle tumor, multiple sclerosis, perilymphatic fistula, perilymphatic fistula can be triggered by loud noises, changes in ear pressure, excessive straining, head trauma.

    Risk Factors

    Common Risk Factors

    Less Common Risk Factors

    • Less common risk factors in the development of vertigo include:
      • Recognized triggers including altered sleep patterns, chocolate, red wine, ripened/aged cheese, can provoke vestibular migraine.
      • Increased stress can cause psychological vertigo.

    References

    1. Hanley K, O’Dowd T, Considine N (2001). “A systematic review of vertigo in primary care”. Br J Gen Pract. 51 (469): 666–71. PMC 1314080. PMID 11510399.
    2. Derebery MJ (1999). “The diagnosis and treatment of dizziness”. Med Clin North Am. 83 (1): 163–77, x. doi:10.1016/s0025-7125(05)70095-x. PMID 9927968.
    3. Rosenberg ML, Gizzi M (2000). “Neuro-otologic history”. Otolaryngol Clin North Am. 33 (3): 471–82. doi:10.1016/s0030-6665(05)70221-8. PMID 10815031.
    Screening

    Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]


    Overview

    There is insufficient evidence to recommend routine screening for vertigo.

    Screening

    There is insufficient evidence to recommend routine screening for vertigo.

    References

    Natural History, Complications and Prognosis

    Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

    Overview

    If left untreated vertigo can affect quality of life and could a symptom of a more serious underlying cause. Common complications include mood instability, falls. Prognosis depends upon the etiology.

    Natural History, Complications and Prognosis

    Natural History

    Complications

    • Complications include:
      • Anxiety
      • Depression
      • Difficulty performing daily tasks
      • Diminished quality of life
      • Impaired balance and coordination
      • Falls

    Prognosis

    • Prognosis of vertigo depends upon treating the underlying cause. However, vertigo due to a tumor has a poor prognosis compared to other causes of vertigo.

    References

    1. Walther LE (2014). “[Dizziness and vertigo in older individuals]”. MMW Fortschr Med. 156 (13): 48–52, quiz 53. PMID 25318226.

    Template:WH Template:WS

    Diagnosis

    Diagnosis

    Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | Echocardiography or Ultrasound | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

    Treatment

    Treatment

    Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

    Looking for the patient version?

    Back to the patient-friendly article

    © 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH